<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39355045</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-8880</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in nuclear medicine (Lausanne, Switzerland)</Title><ISOAbbreviation>Front Nucl Med</ISOAbbreviation></Journal><ArticleTitle>Mini review of first-in-human integrin &#x3b1;v&#x3b2;6 PET tracers.</ArticleTitle><Pagination><StartPage>1271208</StartPage><MedlinePgn>1271208</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1271208</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnume.2023.1271208</ELocationID><Abstract><AbstractText>This mini review of clinically-evaluated integrin &#x3b1;v&#x3b2;6 PET-tracers reveals distinct differences in human-biodistribution patterns between linear peptides, including disulfide-stabilized formats, compared to head-to-tail cyclized peptides. All PET tracers mentioned in this mini review were able to delineate disease from normal tissues, but some &#x3b1;v&#x3b2;6 PET tracers are better than others for particular clinical applications. Each &#x3b1;v&#x3b2;6 PET tracer was validated for its ability to bind integrin &#x3b1;v&#x3b2;6 with high affinity. However, all the head-to-tail cyclized peptide PET-tracers reviewed here did not accumulate in the GI-tract, in striking contrast to the linear and disulfide-bonded counterparts currently undergoing clinical evaluation in cancer, IPF and long COVID. Multiple independent investigators have reported the presence of &#x3b2;6 mRNA as well as &#x3b1;v&#x3b2;6 protein in the GI-tract. Currently, there remains further need for biochemical, clinical, and structural data to satisfactorily explain the state-of-the-art in human &#x3b1;v&#x3b2;6-imaging.</AbstractText><CopyrightInformation>&#xa9; 2023 Kimura, Iagaru and Guo.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kimura</LastName><ForeName>Richard H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Radiology, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iagaru</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>H Henry</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Radiology, Stanford University School of Medicine, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nucl Med</MedlineTA><NlmUniqueID>9918470388806676</NlmUniqueID><ISSNLinking>2673-8880</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IPF</Keyword><Keyword MajorTopicYN="N">PET</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">integrin &#x3b1;V&#x3b2;6</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">peptide</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39355045</ArticleId><ArticleId IdType="pmc">PMC11440954</ArticleId><ArticleId IdType="doi">10.3389/fnume.2023.1271208</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ludwig BS, Kessler H, Kossatz S, Reuning U. RGD-binding integrins revisited: how recently discovered functions and novel synthetic ligands (Re-)shape an ever-evolving field. Cancers (Basel). (2021) 13(7):1711. 10.3390/cancers13071711</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13071711</ArticleId><ArticleId IdType="pmc">PMC8038522</ArticleId><ArticleId IdType="pubmed">33916607</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. (2010) 10(1):9&#x2013;22. 10.3390/cancers13071711</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13071711</ArticleId><ArticleId IdType="pmc">PMC4383089</ArticleId><ArticleId IdType="pubmed">20029421</ArticleId></ArticleIdList></Reference><Reference><Citation>Verrecchia F, Chu ML, Mauviel A. Identification of novel TGF-beta/smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem. (2001) 276(20):17058&#x2013;62. 10.1074/jbc.M100754200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M100754200</ArticleId><ArticleId IdType="pubmed">11279127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura RH, Wang L, Shen B, Huo L, Tummers W, Filipp FV, et al. Evaluation of integrin alphavbeta6 cystine knot PET tracers to detect cancer and idiopathic pulmonary fibrosis. Nat Commun. (2019) 10(1):4673. 10.1038/s41467-019-11863-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11863-w</ArticleId><ArticleId IdType="pmc">PMC6791878</ArticleId><ArticleId IdType="pubmed">31611594</ArticleId></ArticleIdList></Reference><Reference><Citation>Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. (1999) 96(3):319&#x2013;28. 10.1016/s0092-8674(00)80545-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)80545-0</ArticleId><ArticleId IdType="pubmed">10025398</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G, Porte J, Weinreb PH, Violette SM, Wallace WA, McKeever TM, et al. Alphavbeta6 integrin may be a potential prognostic biomarker in interstitial lung disease. Eur Respir J. (2015) 46(2):486&#x2013;94. 10.1183/09031936.00210414</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00210414</ArticleId><ArticleId IdType="pubmed">25745053</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandyopadhyay A, Raghavan S. Defining the role of integrin alphavbeta6 in cancer. Curr Drug Targets. (2009) 10(7):645&#x2013;52. 10.2174/138945009788680374</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138945009788680374</ArticleId><ArticleId IdType="pmc">PMC2888263</ArticleId><ArticleId IdType="pubmed">19601768</ArticleId></ArticleIdList></Reference><Reference><Citation>Munger JS, Sheppard D. Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol. (2011) 3(11):a005017. 10.1101/cshperspect.a005017</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a005017</ArticleId><ArticleId IdType="pmc">PMC3220354</ArticleId><ArticleId IdType="pubmed">21900405</ArticleId></ArticleIdList></Reference><Reference><Citation>Moses HL, Roberts AB, Derynck R. The discovery and early days of TGF-beta: a historical perspective. Cold Spring Harb Perspect Biol. (2016) 8(7):1&#x2013;26. 10.1101/cshperspect.a021865</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a021865</ArticleId><ArticleId IdType="pmc">PMC4930926</ArticleId><ArticleId IdType="pubmed">27328871</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagati A, Kumar S, Jiang P, Pyrdol J, Zou AE, Godicelj A, et al. Integrin alphavbeta6-TGFbeta-SOX4 pathway drives immune evasion in triple-negative breast cancer. Cancer Cell. (2021) 39(1):54&#x2013;67. 10.1016/j.ccell.2020.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2020.12.001</ArticleId><ArticleId IdType="pmc">PMC7855651</ArticleId><ArticleId IdType="pubmed">33385331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura RH, Sharifi H, Shen B, Berry GJ. Guo HH. Alpha(v)beta(6) integrin positron emission tomography of lung fibrosis in idiopathic pulmonary fibrosis and long-COVID. Am J Respir Crit Care Med. (2023) 207(12):1633&#x2013;5. 10.1164/rccm.202206-1107IM</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202206-1107IM</ArticleId><ArticleId IdType="pubmed">36693032</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster CC, Davis RA, Hausner SH. Sutcliffe JL. Alpha(v)beta(6)-targeted molecular PET/CT imaging of the lungs after SARS-CoV-2 infection. J Nucl Med. (2020) 61(12):1717&#x2013;9. 10.2967/jnumed.120.255364</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.120.255364</ArticleId><ArticleId IdType="pmc">PMC8679627</ArticleId><ArticleId IdType="pubmed">32948681</ArticleId></ArticleIdList></Reference><Reference><Citation>DiCara D, Rapisarda C, Sutcliffe JL, Violette SM, Weinreb PH, Hart IR, et al. Structure-function analysis of arg-gly-asp helix motifs in alpha v beta 6 integrin ligands. J Biol Chem. (2007) 282(13):9657&#x2013;65. 10.1074/jbc.M610461200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M610461200</ArticleId><ArticleId IdType="pubmed">17244604</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann A, Sauter M, Roesch S, Mier W, Warta R, Debus J, et al. Identification of a novel ITGalpha(v)beta(6)-binding peptide using protein separation and phage display. Clin Cancer Res. (2017) 23(15):4170&#x2013;80. 10.1158/1078-0432.CCR-16-3217</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-16-3217</ArticleId><ArticleId IdType="pubmed">28468949</ArticleId></ArticleIdList></Reference><Reference><Citation>Korsinczky ML, Schirra HJ, Rosengren KJ, West J, Condie BA, Otvos L, et al. Solution structures by 1H NMR of the novel cyclic trypsin inhibitor SFTI-1 from sunflower seeds and an acyclic permutant. J Mol Biol. (2001) 311(3):579&#x2013;91. 10.1006/jmbi.2001.4887</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.2001.4887</ArticleId><ArticleId IdType="pubmed">11493011</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley NG, Steiger K, Hober&#xfc;ck S, Czech N, Zierke MA, Kossatz S, et al. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the &#x201c;cancer integrin&#x201d; alphavbeta6 with ga-68-trivehexin. Eur J Nucl Med Mol Imaging. (2022) 49(4):1136&#x2013;47. 10.1007/s00259-021-05559-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05559-x</ArticleId><ArticleId IdType="pmc">PMC8460406</ArticleId><ArticleId IdType="pubmed">34559266</ArticleId></ArticleIdList></Reference><Reference><Citation>Roesch S, Lindner T, Sauter M, Loktev A, Flechsig P, M&#xfc;ller M, et al. Comparison of the RGD motif-containing alpha(v)beta(6) integrin-binding peptides SFLAP3 and SFITGv6 for diagnostic application in HNSCC. J Nucl Med. (2018) 59(11):1679&#x2013;85. 10.2967/jnumed.118.210013</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.118.210013</ArticleId><ArticleId IdType="pubmed">29674419</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura RH, Cheng Z, Gambhir SS, Cochran JR. Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res. (2009) 69(6):2435&#x2013;42. 10.1158/0008-5472.CAN-08-2495</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-08-2495</ArticleId><ArticleId IdType="pmc">PMC2833353</ArticleId><ArticleId IdType="pubmed">19276378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura RH, Levin AM, Cochran FV, Cochran JR. Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity. Proteins. (2009) 77(2):359&#x2013;69. 10.1002/prot.22441</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.22441</ArticleId><ArticleId IdType="pmc">PMC5792193</ArticleId><ArticleId IdType="pubmed">19452550</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltsev OV, Marelli UK, Kapp TG, Di Leva FS, Di Maro S, Nieberler M, et al. Stable peptides instead of stapled peptides: highly potent alphavbeta6-selective integrin ligands. Angew Chem Int Ed Engl. (2016) 55(4):1535&#x2013;9. 10.1002/anie.201508709</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201508709</ArticleId><ArticleId IdType="pubmed">26663660</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, Wang Y, Lu D, Xu X, Zhou X, Zhang H, et al. Clinical translation of a (68)Ga-labeled integrin alpha(v)beta(6)-targeting cyclic radiotracer for PET imaging of pancreatic cancer. J Nucl Med. (2020) 61(10):1461&#x2013;7. 10.2967/jnumed.119.237347</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.119.237347</ArticleId><ArticleId IdType="pmc">PMC7539652</ArticleId><ArticleId IdType="pubmed">32086242</ArticleId></ArticleIdList></Reference><Reference><Citation>Baranyai Z, Reich D, V&#xe1;gner A, Weineisen M, T&#xf3;th I, Wester HJ, et al. A shortcut to high-affinity ga-68 and cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform. Dalton Trans. (2015) 44(24):11137&#x2013;46. 10.1039/c5dt00576k</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c5dt00576k</ArticleId><ArticleId IdType="pubmed">25999035</ArticleId></ArticleIdList></Reference><Reference><Citation>Keat N, Kenny J, Chen K, Onega M, Garman N, Slack RJ, et al. A microdose PET study of the safety, immunogenicity, biodistribution, and radiation dosimetry of (18)F-FB-A20FMDV2 for imaging the integrin alpha(v)beta(6). J Nucl Med Technol. (2018) 46(2):136&#x2013;43. 10.2967/jnmt.117.203547</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnmt.117.203547</ArticleId><ArticleId IdType="pubmed">29438002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukey PT, Coello C, Gunn R, Parker C, Wilson FJ, Saleem A, et al. Clinical quantification of the integrin alphavbeta6 by [(18)F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL study). Eur J Nucl Med Mol Imaging. (2020) 47(4):967&#x2013;79. 10.1007/s00259-019-04586-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-019-04586-z</ArticleId><ArticleId IdType="pmc">PMC7075837</ArticleId><ArticleId IdType="pubmed">31814068</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukey PT, Wilson FJ. Quantification of the alpha (v) beta (6) integrin by PET/CT imaging in the lungs of patients after SARS-CoV2 infection and comparison to fibrotic lungs. J Nucl Med. (2022) 63(1):166. 10.2967/jnumed.121.262342</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.262342</ArticleId><ArticleId IdType="pmc">PMC8717206</ArticleId><ArticleId IdType="pubmed">33837070</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher TM, Simpson JK, Porter JC, Wilson FJ, Chan R, Eames R, et al. A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled alphavbeta6 integrin inhibitor. Respir Res. (2020) 21(1):75. 10.1186/s12931-020-01339-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01339-7</ArticleId><ArticleId IdType="pmc">PMC7099768</ArticleId><ArticleId IdType="pubmed">32216814</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem A, Helo Y, Win Z, Dale R, Cook J, Searle GE, et al. Integrin alphavbeta6 positron emission tomography imaging in lung cancer patients treated with pulmonary radiation therapy. Int J Radiat Oncol Biol Phys. (2020) 107(2):370&#x2013;6. 10.1016/j.ijrobp.2020.02.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijrobp.2020.02.014</ArticleId><ArticleId IdType="pubmed">32060008</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausner SH, Bold RJ, Cheuy LY, Chew HK, Daly ME, Davis RA, et al. Preclinical development and first-in-human imaging of the integrin alpha(v)beta(6) with [(18)F]alpha(v)beta(6)-binding peptide in metastatic carcinoma. Clin Cancer Res. (2019) 25(4):1206&#x2013;15. 10.1158/1078-0432.CCR-18-2665</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-18-2665</ArticleId><ArticleId IdType="pmc">PMC6377828</ArticleId><ArticleId IdType="pubmed">30401687</ArticleId></ArticleIdList></Reference><Reference><Citation>Luckett S, Garcia RS, Barker JJ, Konarev AV, Shewry PR, Clarke AR, et al. High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. J Mol Biol. (1999) 290(2):525&#x2013;33. 10.1006/jmbi.1999.2891</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmbi.1999.2891</ArticleId><ArticleId IdType="pubmed">10390350</ArticleId></ArticleIdList></Reference><Reference><Citation>Flechsig P, Lindner T, Loktev A, Roesch S, Mier W, Sauter M, et al. PET/CT imaging of NSCLC with a alpha(v)beta(6) integrin-targeting peptide. Mol Imaging Biol. (2019) 21(5):973&#x2013;83. 10.1007/s11307-018-1296-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11307-018-1296-6</ArticleId><ArticleId IdType="pubmed">30671741</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura RH, Teed R, Hackel BJ, Pysz MA, Chuang CZ, Sathirachinda A, et al. Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer. Clin Cancer Res. (2012) 18(3):839&#x2013;49. 10.1158/1078-0432.CCR-11-1116</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-11-1116</ArticleId><ArticleId IdType="pmc">PMC3271184</ArticleId><ArticleId IdType="pubmed">22173551</ArticleId></ArticleIdList></Reference><Reference><Citation>Heitz A, Hernandez JF, Gagnon J, Hong TT, Pham TT, Nguyen TM, et al. Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins. Biochemistry. (2001) 40(27):7973&#x2013;83. 10.1021/bi0106639</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0106639</ArticleId><ArticleId IdType="pubmed">11434766</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez JF, Gagnon J, Chiche L, Nguyen TM, Andrieu JP, Heitz A, et al. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Biochemistry. (2000) 39(19):5722&#x2013;30. 10.1021/bi9929756</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi9929756</ArticleId><ArticleId IdType="pubmed">10801322</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiche L, Heitz A, Gelly JC, Gracy J, Chau PT, Ha PT, et al. Squash inhibitors: from structural motifs to macrocyclic knottins. Curr Protein Pept Sci. (2004) 5(5):341&#x2013;9. 10.2174/1389203043379477</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203043379477</ArticleId><ArticleId IdType="pubmed">15551519</ArticleId></ArticleIdList></Reference><Reference><Citation>Cemazar M, Joshi A, Daly NL, Mark AE, Craik DJ. The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein. Structure. (2008) 16(6):842&#x2013;51. 10.1016/j.str.2008.02.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2008.02.023</ArticleId><ArticleId IdType="pubmed">18547517</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly NL, Clark RJ, Craik DJ. Disulfide folding pathways of cystine knot proteins. Tying the knot within the circular backbone of the cyclotides. J Biol Chem. (2003) 278(8):6314&#x2013;22. 10.1074/jbc.M210492200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M210492200</ArticleId><ArticleId IdType="pubmed">12482862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamoto R, Ferri V, Duan H, Hatami N, Goel M, Rosenberg J, et al. Pilot-phase PET/CT study targeting integrin alphavbeta6 in pancreatic cancer patients using the cystine-knot peptide-based (18)F-FP-R01-MG-F2. Eur J Nucl Med Mol Imaging. (2022) 50(1):184&#x2013;93. 10.1007/s00259-021-05595-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05595-7</ArticleId><ArticleId IdType="pubmed">34729628</ArticleId></ArticleIdList></Reference><Reference><Citation>Aumailley M, Gurrath M, M&#xfc;ller G, Calvete J, Timpl R, Kessler H. Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1. FEBS Lett. (1991) 291(1):50&#x2013;4. 10.1016/0014-5793(91)81101-d</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(91)81101-d</ArticleId><ArticleId IdType="pubmed">1718779</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank AO, Otto E, Mas-Moruno C, Schiller HB, Marinelli L, Cosconati S, et al. Conformational control of integrin-subtype selectivity in isoDGR peptide motifs: a biological switch. Angew Chem Int Ed Engl. (2010) 49(48):9278&#x2013;81. 10.1002/anie.201004363</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201004363</ArticleId><ArticleId IdType="pubmed">20957712</ArticleId></ArticleIdList></Reference><Reference><Citation>Quigley NG, Czech N, Sendt W, Notni J. PET/CT imaging of pancreatic carcinoma targeting the &#x201c;cancer integrin&#x201d; alphavbeta6. Eur J Nucl Med Mol Imaging. (2021) 48(12):4107&#x2013;8. 10.1007/s00259-021-05443-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05443-8</ArticleId><ArticleId IdType="pmc">PMC8484182</ArticleId><ArticleId IdType="pubmed">34109438</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagerberg L, Hallstr&#xf6;m BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. (2014) 13(2):397&#x2013;406. 10.1074/mcp.M113.035600</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M113.035600</ArticleId><ArticleId IdType="pmc">PMC3916642</ArticleId><ArticleId IdType="pubmed">24309898</ArticleId></ArticleIdList></Reference><Reference><Citation>Koivisto L, Bi J, H&#xe4;kkinen L, Larjava H. Integrin alphavbeta6: structure, function and role in health and disease. Int J Biochem Cell Biol. (2018) 99:186&#x2013;96. 10.1016/j.biocel.2018.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2018.04.013</ArticleId><ArticleId IdType="pubmed">29678785</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng BS, Chen X, Li P, Zheng PY, Chong J, Cho DB, et al. Expression of integrin alphavbeta6 in the intestinal epithelial cells of patients with inflammatory bowel disease. N Am J Med Sci. (2009) 1(4):200&#x2013;4. 10.4297/najms.2009.4200</Citation><ArticleIdList><ArticleId IdType="doi">10.4297/najms.2009.4200</ArticleId><ArticleId IdType="pmc">PMC3364666</ArticleId><ArticleId IdType="pubmed">22666696</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie H, Jiao Y, Zhou X, Liao X, Chen J, Chen H, et al. Integrin alphavbeta6 contributes to the development of intestinal fibrosis via the FAK/AKT signaling pathway. Exp Cell Res. (2022) 411(2):113003. 10.1016/j.yexcr.2021.113003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2021.113003</ArticleId><ArticleId IdType="pubmed">34979108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwada T, Shiokawa M, Kodama Y, Ota S, Kakiuchi N, Nannya Y, et al. Identification of an anti-integrin alphavbeta6 autoantibody in patients with ulcerative colitis. Gastroenterology. (2021) 160(7):2383&#x2013;94. 10.1053/j.gastro.2021.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.02.019</ArticleId><ArticleId IdType="pubmed">33582126</ArticleId></ArticleIdList></Reference><Reference><Citation>Rydell N, Ekoff H, Hellstr&#xf6;m PM, Mov&#xe9;rare R. Measurement of Serum IgG anti-integrin alphavbeta6 autoantibodies is a promising tool in the diagnosis of ulcerative colitis. J Clin Med. (2022) 11(7):1881. 10.3390/jcm11071881</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071881</ArticleId><ArticleId IdType="pmc">PMC8999661</ArticleId><ArticleId IdType="pubmed">35407486</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JK, McAleese SM, Thornton EM, Pate JA, Schock A, Macrae AI, et al. Integrin-alphavbeta6, a putative receptor for foot-and-mouth disease virus, is constitutively expressed in ruminant airways. J Histochem Cytochem. (2006) 54(7):807&#x2013;16. 10.1369/jhc.5A6854.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/jhc.5A6854.2006</ArticleId><ArticleId IdType="pubmed">16517977</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A, Ellison D, Thomas GJ, Vallath S, Mather SJ, Hart IR, et al. High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6. J Pathol. (2010) 222(1):52&#x2013;63. 10.1002/path.2745</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2745</ArticleId><ArticleId IdType="pubmed">20629113</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Chen S, Lu GF, Wu Y, Mo L, Liu ZQ, et al. Alphavbeta6 is required in maintaining the intestinal epithelial barrier function. Cell Biol Int. (2014) 38(6):777&#x2013;81. 10.1002/cbin.10258</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.10258</ArticleId><ArticleId IdType="pubmed">24677750</ArticleId></ArticleIdList></Reference><Reference><Citation>Koide S, Sidhu SS. The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins. ACS Chem Biol. (2009) 4(5):325&#x2013;34. 10.1021/cb800314v</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb800314v</ArticleId><ArticleId IdType="pmc">PMC2829252</ArticleId><ArticleId IdType="pubmed">19298050</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Su Y, Iacob RE, Engen JR, Springer TA. General structural features that regulate integrin affinity revealed by atypical alphaVbeta8. Nat Commun. (2019) 10(1):5481. 10.1038/s41467-019-13248-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13248-5</ArticleId><ArticleId IdType="pmc">PMC6889490</ArticleId><ArticleId IdType="pubmed">31792290</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>